Becton, Dickinson and Company Work in process decreased by 20.0% to $396.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.7%, from $487.00M to $396.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows relatively stable performance with a 1.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $388.00M | $381.00M | $393.00M | $413.00M | $407.00M | $397.00M | $443.00M | $428.00M | $406.00M | $381.00M | $368.00M | $376.00M | $406.00M | $443.00M | $453.00M | $487.00M | $512.00M | $354.00M | $495.00M | $396.00M |
| QoQ Change | — | -1.8% | +3.1% | +5.1% | -1.5% | -2.5% | +11.6% | -3.4% | -5.1% | -6.2% | -3.4% | +2.2% | +8.0% | +9.1% | +2.3% | +7.5% | +5.1% | -30.9% | +39.8% | -20.0% |
| YoY Change | — | — | — | — | +4.9% | +4.2% | +12.7% | +3.6% | -0.2% | -4.0% | -16.9% | -12.1% | +0.0% | +16.3% | +23.1% | +29.5% | +26.1% | -20.1% | +9.3% | -18.7% |
| % of Inventories | 13.2% | 13.9% | 12.9% | 12.7% | 12.9% | 12.3% | 12.3% | 11.7% | 11.3% | 11.6% | 11.1% | 11.6% | 12.5% | 11.5% | 11.7% | 13.1% | 13.0% | 11.2% | 12.1% | 11.8% |
| Share Change | — | +0.7pp | -0.9pp | -0.3pp | +0.2pp | -0.6pp | -0.0pp | -0.6pp | -0.4pp | +0.3pp | -0.5pp | +0.5pp | +0.8pp | -0.9pp | +0.2pp | +1.3pp | -0.1pp | -1.7pp | +0.9pp | -0.3pp |